(NCX) NorthIsle Copper Gold - Ratings and Ratios

Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA66644R1038

NCX: Copper, Gold, Molybdenum, Rhenium

NorthIsle Copper and Gold Inc. (V:NCX) is a junior mineral exploration and development company focused on advancing its flagship North Island Project, a large-scale, multi-deposit mineral property spanning approximately 34,000 hectares on Northern Vancouver Island, British Columbia. The project is prospective for copper, gold, molybdenum, and rhenium, with significant exploration potential due to its strategic location in a region with established infrastructure and access to deepwater ports. The company, incorporated in 2011 and headquartered in Vancouver, Canada, has built a portfolio aimed at unlocking the value of its mineral assets through systematic exploration and development activities. https://www.northisle.ca

From a technical standpoint, NCX is currently trading at $0.70 with a 20-day average volume of 249,800 shares. The stock is below its SMA 20 of $0.73 but above its SMA 50 of $0.65, while the SMA 200 stands at $0.50. The ATR of $0.05 indicates low volatility. Fundamentally, the company has a market capitalization of $177.36M CAD, with a price-to-book ratio of 14.69 and a price-to-sales ratio of 2607.44. The return on equity is negative at -75.47, reflecting current operational challenges.

The stock is expected to remain range-bound between $0.60 and $0.80 over the next three months, with potential resistance at the SMA 20 level of $0.73 and support at the SMA 50 level of $0.65. The low ATR of $0.05 suggests limited price movement, with average daily volatility expected to remain subdued. The companys high price-to-book ratio of 14.69 indicates elevated expectations for future asset performance. However, the negative return on equity of -75.47 highlights ongoing operational inefficiencies. Over the next quarter, market participants will likely focus on the companys ability to advance its North Island Project and improve its financial health. The price-to-sales ratio of 2607.44 suggests investors are pricing in significant future growth.

Additional Sources for NCX Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

NCX Stock Overview

Market Cap in USD 128m
Sector Basic Materials
Industry Other Industrial Metals & Mining
GiC Sub-Industry Diversified Metals & Mining
IPO / Inception

NCX Stock Ratings

Growth Rating 68.7
Fundamental -45.0
Dividend Rating 0.0
Rel. Strength 52.3
Analysts -
Fair Price Momentum 0.84 CAD
Fair Price DCF -

NCX Dividends

No Dividends Paid

NCX Growth Ratios

Growth Correlation 3m 87.6%
Growth Correlation 12m 38.6%
Growth Correlation 5y 57.5%
CAGR 5y 60.39%
CAGR/Max DD 5y 0.84
Sharpe Ratio 12m -0.06
Alpha 34.75
Beta -0.375
Volatility 68.84%
Current Volume 68.9k
Average Volume 20d 249.8k
What is the price of NCX stocks?
As of April 22, 2025, the stock is trading at CAD 0.69 with a total of 68,900 shares traded.
Over the past week, the price has changed by -1.43%, over one month by -1.43%, over three months by +64.29% and over the past year by +40.82%.
Is NorthIsle Copper Gold a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, NorthIsle Copper Gold (V:NCX) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -44.98 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NCX as of April 2025 is 0.84. This means that NCX is currently undervalued and has a potential upside of +21.74% (Margin of Safety).
Is NCX a buy, sell or hold?
NorthIsle Copper Gold has no consensus analysts rating.
What are the forecast for NCX stock price target?
According to ValueRays Forecast Model, NCX NorthIsle Copper Gold will be worth about 0.9 in April 2026. The stock is currently trading at 0.69. This means that the stock has a potential upside of +30.43%.
Issuer Forecast Upside
Wallstreet Target Price 1.4 102.9%
Analysts Target Price - -
ValueRay Target Price 0.9 30.4%